Fulgent Genetics (FLGT) Other Accumulated Expenses (2016 - 2026)

Fulgent Genetics has disclosed Other Accumulated Expenses across 8 years of filings, most recently posting $2.6 million for Q2 2026.

• In Q2 2026, Other Accumulated Expenses fell 48.67% year-over-year to $2.6 million; the TTM figure through Jun 2026 stood at $2.6 million (down 48.67% YoY), while the FY2025 annual figure was $2.8 million, down 21.66% from the prior year.
• Other Accumulated Expenses came in at $2.6 million for Q2 2026 at Fulgent Genetics, up from $2.5 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $13.6 million in Q3 2022 to a low of $281000.0 in Q3 2023.
• Average Other Accumulated Expenses over 5 years is $3.8 million, with a median of $3.7 million recorded in 2024.
• Year-over-year, Other Accumulated Expenses tumbled 97.94% in 2023 and soared 1345.55% in 2024.
• Over 5 years, Other Accumulated Expenses stood at $5.3 million in 2022, then decreased by 20.49% to $4.2 million in 2023, then fell by 13.78% to $3.6 million in 2024, then fell by 21.66% to $2.8 million in 2025, then slipped by 9.31% to $2.6 million in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $2.6 million in Q2 2026, $2.5 million in Q1 2026, and $2.8 million in Q4 2025.